What is CarePredict?
CarePredict is dedicated to empowering caregivers by providing timely insights into the health of seniors. Leveraging the science that activity and behavioral changes precede health deteriorations, the company's flagship product, Tempo, is an award-winning smart wearable. Tempo autonomously monitors daily patterns and alerts professional and family caregivers to changes that require attention. Since its inception in 2013, CarePredict has focused on enhancing peace of mind and improving the quality of life for seniors, whether they are living independently at home or within senior living facilities. The company's mission is deeply rooted in utilizing technology to proactively manage senior well-being.
How much funding has CarePredict raised?
CarePredict has raised a total of $42.5M across 5 funding rounds:
Private Equity
$1M
Private Equity
$2.5M
Debt
$150K
Debt
$364K
Series A
$38.5M
Private Equity (2015): $1M, investors not publicly disclosed
Private Equity (2016): $2.5M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Debt (2021): $364K featuring PPP
Series A (2023): $38.5M backed by Startup Health Ventures, Aspire Healthtech Partners, Las Olas VC, and Secocha Ventures
Key Investors in CarePredict
Las Olas VC
Las Olas Venture Capital is a venture capital firm that focuses on backing founders who are developing AI and software applications aimed at modernizing outdated business workflows. They typically invest between $1.5 million and $3 million in seed-stage companies, with a preference for SaaS and vertical AI industries.
Startup Health Ventures
Startup Health Ventures is an investor focused on companies within the health technology sector, likely seeking to support innovative solutions that address critical healthcare challenges and improve patient outcomes.
Aspire Healthtech Partners
Aspire Healthtech Partners is an investment firm specializing in the health technology space, aiming to foster growth in companies that are developing cutting-edge solutions for healthcare delivery and patient care.
What's next for CarePredict?
The recent major enterprise-level funding positions CarePredict for substantial scaling and further development of its predictive health monitoring platform. This capital infusion is expected to accelerate market penetration, enhance AI capabilities for more nuanced pattern detection, and expand partnerships within the healthcare and senior living sectors. The strategic investment signals strong confidence in CarePredict's business model and its potential to disrupt traditional elder care by shifting from reactive to proactive health management. Future growth will likely involve expanding the Tempo ecosystem and integrating its data with broader healthcare systems to provide a more holistic view of senior health.
See full CarePredict company page
